Global Urinalysis Test Market

Urinalysis Test Market Size, Share, Growth Analysis, By Application(Disease Screening, Pregnancy and Fertility), By End User(Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute), By Test(Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2324 | Region: Global | Published Date: April, 2024
Pages: 220 | Tables: 89 | Figures: 71

Urinalysis Test Market Competitive Landscape

Within the highly competitive global urinalysis test market, several multinational corporations hold a dominant position by providing an extensive array of cutting-edge goods and solutions. Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation are important participants. To be competitive and fulfil the changing needs of customers and healthcare providers around the globe, these organisations concentrate on R&D, strategic alliances, and geographic expansion.

Top Player’s Company Profiles

  • Cardinal Health (US)
  • General Electric Company (US)
  • Metropolis India (India)
  • 77 Elektronika Kft (Hungary)
  • Roche Diagnostics (Switzerland)
  • Thermo Fisher Scientific (US)
  • Sysmex Corporation (Japan)
  • Abbott (US)
  • Trinity Biotech (Ireland)
  • ARKRAY Inc. (Japan)
  • Dr Lal PathLabs (India)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens (Germany)
  • Sysmex Corporation (Japan)
  • BioMaxima SA (Poland)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Urinalysis Test Market size was valued at USD 2.14 billion in 2022, USD 2.24 billion in 2023 and is projected to grow USD 3.09 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).

Within the highly competitive urinalysis test market, several multinational corporations hold a dominant position by providing an extensive array of cutting-edge goods and solutions. Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation are important participants. To be competitive and fulfil the changing needs of customers and healthcare providers around the globe, these organisations concentrate on R&D, strategic alliances, and geographic expansion. 'Cardinal Health (US)', 'General Electric Company (US)', 'Metropolis India (India) ', '77 Elektronika Kft (Hungary)', 'Roche Diagnostics (Switzerland) ', 'Thermo Fisher Scientific (US)', 'Sysmex Corporation (Japan)', 'Abbott (US)', 'Trinity Biotech (Ireland)', 'ARKRAY Inc. (Japan)', 'Dr Lal PathLabs (India) ', 'F. Hoffmann-La Roche Ltd (Switzerland)', ' Siemens (Germany)', 'Sysmex Corporation (Japan)', 'BioMaxima SA (Poland)'

Rising urinary tract infection (UTI) rates in developing economies are one of the main factors driving the market ahead. Urinary tract infections (UTIs) have the potential to create complications during childbirth and extend to the kidneys if treatment is not received, which could drive market expansion.

Revolutionizing Urinalysis: The development of diagnostic technology is one of the most significant advances in urine analysis testing. The results of urinalysis are getting better thanks to automated urine analyzers and smartphone-based testing devices. Both patients and medical professionals may now test more easily and simply thanks to these developments. Urinalysis tests become more and more necessary as chronic conditions like diabetes and renal disease progress. The market is growing as urinalysis is useful for treating and keeping track of these conditions. In today's healthcare, urinalysis is essential since it can identify health problems early.

The market for urinalysis tests is dominated by North America due to the rise in chronic kidney and liver illnesses as well as diabetes. During the projected period, the expansion of the urinalysis test market in the area would be further aided by technological advancements. In North America, diabetes is a common chronic illness that is linked to aberrant urine composition. The urinalysis test market is expected to grow significantly in Asia-Pacific because of local enterprises increased technical advancements. The presence of medical equipment businesses in the region and the rise in the purchasing power of populous nations like China and India are responsible for the market's expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Urinalysis Market
Buy Now GET FREE SAMPLE
Urinary Tract Infection Testing Market
Buy Now GET FREE SAMPLE
Kidney Function Test Market
Buy Now GET FREE SAMPLE
Drug Testing Market
Buy Now GET FREE SAMPLE
Clinical Laboratory Tests Market
Buy Now GET FREE SAMPLE
Ureteroscope Market
Buy Now GET FREE SAMPLE
Nephrology And Urology Devices Market
Buy Now GET FREE SAMPLE
Blood Testing Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Urinalysis Test Market

Report ID: SQMIG35I2324

$5,300
BUY NOW GET FREE SAMPLE